These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 6638052

  • 1. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG, Prescott RW, Kendall-Taylor P, Hall K, Crombie AL, Hall R, McGregor A, Watson MJ, Cook DB.
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [Abstract] [Full Text] [Related]

  • 2. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M, Rydner T, Carlström K.
    Acta Obstet Gynecol Scand; 1980 Nov; 59(2):137-41. PubMed ID: 6773290
    [Abstract] [Full Text] [Related]

  • 3. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T, Nillius SJ, Wide L.
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [Abstract] [Full Text] [Related]

  • 4. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ, Bergh T, Lundberg PO, Stahle J, Wide L.
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [Abstract] [Full Text] [Related]

  • 5. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy.
    van Roon E, van der Vijver JC, Gerretsen G, Hekster RE, Wattendorff RA.
    Fertil Steril; 1981 Aug; 36(2):173-7. PubMed ID: 6790306
    [Abstract] [Full Text] [Related]

  • 6. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY, Jarrett JC, Choe JK.
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [Abstract] [Full Text] [Related]

  • 7. Hyperprolactinemia and hypogonadism in the human female.
    Rolland R, Corbey RS.
    Eur J Obstet Gynecol Reprod Biol; 1977 Oct; 7(5):337-48. PubMed ID: 400856
    [Abstract] [Full Text] [Related]

  • 8. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E, Schivardi MR, Falsetti L, Gastaldi A.
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [Abstract] [Full Text] [Related]

  • 9. The use of bromocriptine in hyperprolactinemia and galactorrhea in Singapore.
    Tsakok FH, Yong YM, Ng CS.
    Int J Gynaecol Obstet; 1985 Apr; 23(2):109-13. PubMed ID: 2862070
    [Abstract] [Full Text] [Related]

  • 10. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM, Mashchak CA, Chang RJ.
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [Abstract] [Full Text] [Related]

  • 11. The effects of pregnancy on patients with hyperprolactinemia.
    Samaan NA, Leavens ME, Sacca R, Smith K, Schultz PN.
    Am J Obstet Gynecol; 1984 Feb 15; 148(4):466-73. PubMed ID: 6696005
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ.
    Acta Eur Fertil; 1984 Feb 15; 15(2):83-91. PubMed ID: 6475464
    [Abstract] [Full Text] [Related]

  • 14. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A, Crespo G, Coria I, Espinosa de los Monteros A.
    Int J Fertil Menopausal Stud; 1995 Feb 15; 40(2):96-101. PubMed ID: 7599666
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia.
    Lamberts SW, Quik RF.
    J Clin Endocrinol Metab; 1991 Mar 15; 72(3):635-41. PubMed ID: 1997518
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Ayalon D, Eckstein N, Avidan S, Eshel A, L'Hermite M, Caufriez A, Spitz I, Zylber-Haran E.
    Gynecol Obstet Invest; 1983 Mar 15; 16(2):97-106. PubMed ID: 6413305
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M, Nicastri PL, Diaferia A, Di Gesù I, Loizzi P.
    Clin Exp Obstet Gynecol; 1995 Mar 15; 22(4):301-6. PubMed ID: 8777784
    [Abstract] [Full Text] [Related]

  • 18. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C, Tena G, Fonseca ME, Ochoa R, Bermúdez JA, Zárate A.
    Arch Med Res; 1994 Mar 15; 25(1):1-3. PubMed ID: 8019107
    [Abstract] [Full Text] [Related]

  • 19. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
    Lamberts SW, Docter R, De Jong FH, Birkenhäger JC, Kwa HG.
    Fertil Steril; 1978 Mar 15; 29(3):287-90. PubMed ID: 346383
    [Abstract] [Full Text] [Related]

  • 20. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
    Rasmussen C, Bergh T, Nillius SJ, Wide L.
    Fertil Steril; 1985 Jul 15; 44(1):31-4. PubMed ID: 4007192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.